Evaluating reliable suppliers for Chonluten (EDG tripeptide) requires strict verification of sequence purity, low endotoxin levels, and certified structural identity. PX1 Research provides high-purity, USA-manufactured Chonluten specifically synthesized for laboratory investigation into epigenetic gene expression, respiratory tissue homeostasis, and antioxidant enzyme regulation. Every lot is paired with comprehensive third-party COA data, ensuring analytical precision for rigorous in vitro and preclinical models.
Evaluating reliable suppliers for Chonluten (EDG tripeptide) requires strict verification of sequence purity, low endotoxin levels, and certified structural identity. PX1 Research provides high-purity, USA-manufactured Chonluten specifically synthesized for laboratory investigation into epigenetic gene expression, respiratory tissue homeostasis, and antioxidant enzyme regulation. Every lot is paired with comprehensive third-party COA data, ensuring analytical precision for rigorous in vitro and preclinical models.
Procurement of research-grade Chonluten requires selecting a supplier capable of delivering verified tripeptide sequence purity (Glu-Asp-Gly) free from endotoxin contamination. PX1 Research supplies USA-manufactured Chonluten for laboratory investigation into antioxidant enzyme regulation, providing lot-specific RP-HPLC, mass spectrometry, and ISO 17025 third-party certification to guarantee reproducibility in cell culture and animal models.
When purchasing synthetic peptides for biochemical and cellular assays, principal investigators must ensure that candidate compounds meet stringent analytical thresholds. Low-grade synthesis often introduces truncated peptide sequences, residual TFA salts, or heavy metal impurities that obscure experimental outcomes. At PX1 Research, our catalog of all peptides undergoes rigorous quality control, providing researchers with the analytical confidence necessary to generate publishable, reproducible data.
Chonluten is a short synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and L-glycine, represented structurally as H-Glu-Asp-Gly-OH (EDG). With a molecular weight of approximately 305.24 g/mol, this acidic short peptide belongs to the bioregulatory peptide class developed to evaluate chromatin condensation and gene expression modulation in specific target tissues.
The small molecular footprint of H-Glu-Asp-Gly-OH allows it to interact directly with nuclear structures and specific peptide binding sites in preclinical models. In laboratory settings, researchers examine how the precise side-chain charges of glutamic acid and aspartic acid contribute to its binding affinity and structural stability in aqueous buffer systems.
Preclinical studies suggest that Chonluten exerts its biological effects primarily through epigenetic mechanisms, specifically by interacting with histone proteins and specific DNA sequences. In vitro models demonstrate that short peptides like EDG can penetrate cellular and nuclear membranes to induce local chromatin unfolding. This structural shift enhances promoter accessibility for key endogenously expressed enzymes.
Investigations utilizing our Chonluten peptide focus largely on the transcriptional upregulation of primary antioxidant enzymes. In vitro data indicate that exposure to EDG increases the messenger RNA (mRNA) expression and enzymatic activity of Superoxide Dismutase (SOD), Glutathione Peroxidase (GPx), and Catalase (CAT). By enhancing the endogenous expression of these enzymatic cascades, the compound provides a controlled model for studying cellular defense mechanisms against hydrogen peroxide and superoxide radical accumulation. Researchers interested in broader oxidative stress pathways can review our dedicated research library hub for technical whitepapers.
In respiratory research models, Chonluten has been widely studied for its ability to maintain epithelial barrier integrity under induced oxidative or inflammatory stress. Preclinical rodent models evaluating acute pulmonary injury indicate that administration of EDG correlates with reduced lipid peroxidation markers (such as malondialdehyde) and diminished inflammatory cytokine signaling (including TNF-alpha and IL-6).
Cellular assays utilizing human bronchial epithelial cell lines show that pre-treatment with Chonluten mitigates ROS-induced necrosis and apoptotic signaling. By normalizing the balance between reactive oxygen species generation and enzymatic neutralization, the tripeptide serves as a valuable tool for investigating chronic airway inflammation, tissue remodeling, and cellular repair kinetics.
Understanding where Chonluten fits within the broader landscape of short bioregulatory sequences is essential for proper assay design. Researchers often compare EDG against structurally or functionally related compounds to evaluate target selectivity and differential gene expression patterns.
In direct comparative studies, Bronchogen (Ala-Glu-Asp-Leu) targets similar respiratory epithelial pathways but possesses a tetrapeptide backbone with distinct hydrophobic properties due to its terminal leucine residue. Conversely, Epithalon (Ala-Glu-Asp-Gly) incorporates an alanine residue at the N-terminus and is primarily investigated for telomerase activation and neuroendocrine regulation rather than localized bronchial protection. For a comprehensive taxonomy of these short peptide complexes, consult our technical guide on bioregulatory peptide mechanisms.
When sourcing peptides for high-throughput screening or cell culture research, purity metrics are paramount. Inferior manufacturing processes can lead to incomplete sequence assembly, resulting in deletion sequences that yield false-positive or false-negative bioactivity readings.
PX1 Research enforces strict quality benchmarks for every production batch. All compounds undergo High-Performance Liquid Chromatography (RP-HPLC) to confirm peptide purity exceeding 98%, alongside Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular mass. Furthermore, because bacterial lipopolysaccharides (endotoxins) can trigger non-specific inflammatory signaling in cell cultures, every lot undergoes chromogenic LAL testing to ensure endotoxin levels remain below strictly controlled research thresholds (<0.01 EU/mg).
Proper reconstituting and storage protocols are essential to preserve the structural stability and bioactivity of lyophilized Chonluten. Upon receipt, the lyophilized powder should be stored in a freezer at -20°C or -80°C, protected from light and moisture.
For reconstituting in a laboratory environment, use sterile, nuclease-free water or sterile phosphate-buffered saline (PBS, pH 7.4). The peptide dissolves readily in aqueous media due to the presence of polar carboxyl groups on the glutamic and aspartic acid residues. Once reconstituted, stock solutions should be divided into single-use aliquots and stored at -80°C to eliminate damage caused by repeated freeze-thaw cycles. Working solutions kept at 4°C should be utilized within 24 to 48 hours to prevent hydrolysis or bacterial contamination.
PX1 Research is dedicated to supporting academic, biotech, and institutional laboratories with ultra-pure research compounds. All our peptides are synthesized in state-of-the-art cGMP-compliant facilities within the United States, adherence to ISO 9001 and ISO 17025 laboratory standards.
To facilitate uninterrupted research schedules, PX1 Research maintains centralized inventory facilities in California and Arizona, offering same-day dispatch for orders placed Monday through Friday prior to standard cutoff times. Institutional buyers seeking large-scale custom synthesis or bulk supply agreements can explore our wholesale supplier portal for specialized volume pricing and dedicated Account Executive support.
Transparency is the cornerstone of empirical research. PX1 Research provides downloadable, lot-specific Certificates of Analysis (COAs) for every peptide product in our inventory. These documents detail the exact analytical methods applied and provide raw spectroscopic output.
When reviewing a PX1 Certificate of Analysis for Chonluten, researchers can inspect the RP-HPLC chromatogram to verify peak integration area, proving sequence homogeneity. The accompanying mass spectrum confirms the presence of the expected single-charged [M+H]+ and sodium-adduct ions matching the theoretical molecular weight of EDG. Additional test results confirm moisture content, residual counter-ion concentrations, and verified microbiological testing.
Integrating Chonluten into established experimental protocols—such as Western blotting, real-time quantitative PCR (RT-qPCR), or flow cytometry ROS detection assays—requires consistent lot-to-lot bioactivity. Variations in salt form or peptide content can skew quantitative concentration measurements.
PX1 Research ensures lot-to-lot consistency by standardizing our lyophilization parameters and counter-ion exchange processes. Laboratories examining oxidative stress cascades can cross-reference findings with other compounds in our specialized guide on antioxidant peptide research. Our technical support team is available to assist laboratory managers with bulk order specifications, custom vial configurations, and analytical data verification.
What is the sequence and chemical identity of Chonluten?
Chonluten is a synthetic tripeptide with the amino acid sequence L-glutamyl-L-aspartyl-glycine (H-Glu-Asp-Gly-OH or EDG). It has a theoretical molecular weight of 305.24 g/mol.
How does Chonluten influence antioxidant enzyme regulation in vitro?
Preclinical studies demonstrate that Chonluten interacts with nuclear chromatin to induce localized gene transcription, resulting in upregulated mRNA expression and higher enzymatic activity of Superoxide Dismutase (SOD), Catalase (CAT), and Glutathione Peroxidase (GPx).
What purity level is guaranteed for PX1 Research Chonluten?
PX1 Research provides Chonluten at a purity standard of ≥98%, verified by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (ESI-MS).
How does Chonluten differ structurally from Bronchogen?
Chonluten is a tripeptide (Glu-Asp-Gly), whereas Bronchogen is a tetrapeptide with the sequence Ala-Glu-Asp-Leu. While both are studied in pulmonary tissue models, their sequence variations alter their hydrophobic interaction profiles and specific gene promoter affinities.
What solvent is recommended for reconstituting Chonluten in the laboratory?
Chonluten is readily soluble in sterile nuclease-free water or sterile phosphate-buffered saline (PBS, pH 7.4). Solvents containing high organic concentrations are typically unnecessary due to the peptide's hydrophilic nature.
How does PX1 Research test for endotoxin levels in peptide lots?
Every peptide lot undergoes rigorous Limulus Amebocyte Lysate (LAL) chromogenic assay testing in an ISO 17025 accredited laboratory to verify that endotoxin levels remain strictly below <0.01 EU/mg.
What are the recommended long-term storage conditions for lyophilized Chonluten?
Lyophilized Chonluten should be stored at -20°C or -80°C in a desiccated environment protected from direct light exposure to maintain long-term peptide stability.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in cGMP-compliant facilities within the USA and shipped directly from distribution hubs located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.